Dec 01, 2021 / 07:00PM GMT
Edward Andrew Tenthoff - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Good afternoon, everyone. My name is Ted Tenthoff. I'm a senior biotechnology analyst at Piper Sandler. Thanks for joining us for this year's Virtual Healthcare Conference. Sorry for the slight delay, but as you guys know, Stephen Hoge, President of Moderna literally is on the front lines of fighting Omicron. So we're going to jump right in.
Questions and Answers:
Edward Andrew Tenthoff - Piper Sandler & Co., Research Division - MD & Senior Research AnalystStephen, what can you tell us about this new variant and retain protection by the current vaccines?
Stephen Hoge - Moderna, Inc. - President
Well, first, I want to say thank you, Ted. We'll jump right in, of course. I do apologize to everybody for being a few minutes late here. As you can imagine, we're urgently dealing with some things related to Omicron, which makes us a very good starting question. So where -- we don't know yet, is the short
Trustpilot
